Information about Saint-Gilles Pharma
My details
*
*
*

Saint-Gilles Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0712.909.319

VAT liability
Yes
Established
07-11-2018
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Saint-Gilles Pharma

2024 2023 2022 2021
Profit/Loss 18,303 479 % -4,828 -168 % 7,086 -90 % 73,313
Equity 241,654 8 % 223,352 -2 % 228,180 3 % 221,094
Gross margin 85,745 41 % 60,782 -50 % 120,585 -51 % 246,483
Employees 0.9 0.9

Publications from Saint-Gilles Pharma

Date Publication
02-01-2024 Modification Legal Form - Resignations, Appointments (FR)
09-11-2018 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Saint-Gilles Pharma?
The VAT number of Saint-Gilles Pharma is BE 0712.909.319.
Wat is the PEPPOL ID of Saint-Gilles Pharma?
The PEPPOL ID of Saint-Gilles Pharma is 0208:0712909319. Log in or start a free trial to see the full overview.
When was Saint-Gilles Pharma founded?
Saint-Gilles Pharma was founded on 07-11-2018.
What is the address of Saint-Gilles Pharma?
The current registered office of Saint-Gilles Pharma is located at Rue Saint-Gilles 278, 4000 Liège.
When was the last time Saint-Gilles Pharma filed their annual financial statements?
The most recent financial statements of Saint-Gilles Pharma were filed on 14-07-2025.
How many employees does Saint-Gilles Pharma have?
There are currently no employees working at Saint-Gilles Pharma or no workforce information is available.
What is the annual turnover of Saint-Gilles Pharma?
At the time of its most recent financial statements, Saint-Gilles Pharma did not publish any turnover figures. Saint-Gilles Pharma reported a gross margin of €85,745.18.